DEFINITIVE PROXY

Company

Phio Pharmaceuticals Corp.

Filed

July 30, 2025

Period of Report

September 11, 2025

Accession Number

0001683168-25-005520

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →